Overview
Studies Have Demonstrated a Reduction in Time to Hemostasis and Ambulation When Compared to Manual Compression2
>50%
Reduction
in mean hold time2
>20%
Reduction
in ambulation time2
CATALYST is designed to provide temporary hemostasis and enhance coagulation for patients requiring manual compression – helping to reduce mean hold time by over 50% and reduce time to ambulation by more than 20% as compared to manual compression.2
- Enhances tissue apposition, natural elastic recoil and coagulation
- Helps maintain vessel integrity
- Supports the body’s natural healing process
- Allows immediate reaccess with no part of the device left behind
- More efficient for clinical staff and more comfortable for patients
CATALYST Activates Clotting and Promotes Coagulation
The CATALYST II and CATALYST III manual compression assist devices employ Cardiva’s proven proprietary collapsible disc technology and two different hemostatic coatings based on the presence of heparin. CATALYST II is coated with kaolin and chitosan used to promote coagulation by activating the clotting cascade and causing platelet aggregation. CATALYST III is coated with an additional drug, protamine sulfate, acting locally to neutralize heparin and further aid the body’s natural healing process.
2Data from BOOM II Investigator-Initiated Clinical Study with manuscript submitted for publication. Note: FDA has not reviewed reduced TTH or TTA data.
CATALYST Videos and Literature
